Resistance Selection Studies Comparing the Activity of Razupenem (PTZ601) to Vancomycin and Linezolid against Eight Methicillin-Resistant and Two Methicillin-Susceptible Staphylococcus aureus Strains

被引:12
作者
Clark, Catherine [1 ]
Kosowska-Shick, Klaudia [1 ]
McGhee, Pamela [1 ]
Dewasse, Bonifacio [1 ]
Beachel, Linda [1 ]
Appelbaum, Peter C. [1 ]
机构
[1] Penn State Univ, Milton S Hershey Med Ctr, Dept Pathol, Hershey, PA 17033 USA
关键词
ANTISTAPHYLOCOCCAL ACTIVITY; CARBAPENEM; SM-216601; MEROPENEM; SMP-601; AGENTS;
D O I
10.1128/AAC.00183-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Multistep and single-step resistance selection studies were performed with razupenem, linezolid, and vancomycin against 10 methicillin (meticillin)-resistant and -susceptible Staphylococcus aureus strains. After 20 daily subcultures, razupenem yielded only clones with MICs of > 4 mu g/ml in one strain (8 mu g/ml) whose parent's MIC was already 4 mu g/ml. After 18 to 49 passages in 6/10 strains, razupenem MICs rose from 0.016 to 2 mu g/ml (parents) to 0.125 to 8 mu g/ml (with clones stable after 10 drug-free subcultures). Single-step mutant selection frequencies were similarly low for razupenem and comparators.
引用
收藏
页码:3118 / 3121
页数:4
相关论文
共 17 条
[1]  
[Anonymous], [No title captured]
[2]   Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA) [J].
Appelbaum, Peter C. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (05) :398-408
[3]   Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents [J].
Bogdanovich, T ;
Esel, D ;
Kelly, LM ;
Bozdogan, B ;
Credito, K ;
Lin, GR ;
Smith, K ;
Ednie, LM ;
Hoellman, DB ;
Appelbaum, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) :3325-3333
[4]   Antistaphylococcal activity of CG400549, a new experimental FabI inhibitor, compared with that of other agents [J].
Bogdanovich, Tatiana ;
Clark, Catherine ;
Kosowska-Shick, Klaudia ;
Dewasse, Bonifacio ;
McGhee, Pamela ;
Appelbaum, Peter C. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (11) :4191-4195
[5]  
*CIT NY DEP HLTH M, 2007, AL 31 SURV VANC RES
[6]  
Clinical and Laboratory Standards Institute, 2006, METH DIL ANT SUSC TE, V7
[7]   Control and outcome of a large outbreak of colonization and infection with glycopeptide-intermediate Staphylococcus aureus in an intensive care unit [J].
de Lassence, A ;
Hidri, N ;
Timsit, JF ;
Joly-Guillou, ML ;
Thiery, G ;
Boyer, A ;
Lable, P ;
Blivet, A ;
Kalinowski, H ;
Martin, Y ;
Lajonchere, JP ;
Dreyfuss, D .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (02) :170-178
[8]   Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis [J].
Julian, Kathleen ;
Kosowska-Shick, Klaudia ;
Whitener, Cynthia ;
Roos, Martin ;
Labischinski, Harald ;
Rubio, Aileen ;
Parent, Leslie ;
Ednie, Lois ;
Koeth, Laura ;
Bogdanovich, Tatiana ;
Appelbaum, Peter C. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (09) :3445-3448
[9]   Potency of SMP-601, a novel carbapenem, in hematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus [J].
Kihara, Rie ;
Yanagihara, Katsunori ;
Morinaga, Yoshitomo ;
Araki, Nobuko ;
Nakamura, Shigeki ;
Seki, Masafumi ;
Izumikawa, Koichi ;
Kakeya, Hiroshi ;
Yamamoto, Yoshihiro ;
Tsukamoto, Kazuhiro ;
Kamihira, Shimeru ;
Kohn, Shigeru .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (06) :2163-2168
[10]   Effects of low temperature and high salt on the activity of the novel carbapenem PZ-601 (SMP-601) against methicillin-resistant Staphylococcus aureus [J].
Livermore, David M. ;
Warner, Marina .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (02) :411-413